Tesla Sales Crash in Europe as BYD Makes Bond Market Waves
Exclusive analysis of Tesla's significant European sales decline in July, BYD's bond market surge, and the ripple effects across the FTSE. Key insights for investors and industry watchers.
Category : Search result: pharmaceutical sales
Streeting's Tough Stance on Pharma Deal Sparks Industry Backlash
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.
Bank Holiday Shopping: Save Up to 50% in UK Sales
UK shoppers set for massive Bank Holiday savings with discounts up to 50% across retail, fashion, tech and homeware. Your ultimate guide to the biggest deals.
UK Retail Sales Crash Amid Soaring Inflation
New data reveals a sharp decline in UK retail sales, with like-for-like growth turning negative. Soaring food inflation and the cost-of-living crisis are forcing consumers to cut back severely on non-essential spending.
Trump Tariffs Threaten UK Access to Weight-Loss Drugs
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Streeting Confronts Pharma Giants Over NHS Drug Pricing
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
Novartis Accused of Exploiting WHO Scheme in Africa
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
Mounjaro and Ozempic prices surge amid high demand
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Ozempic & Mounjaro Prices Rise Due to Trump Tariffs
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Eli Lilly hikes Mounjaro price in UK for 2025
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Pam Bondi Under Fire for Alleged Pharma Lobbying
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
Pharma exec charged in fatal wrong-way crash
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
Mounjaro maker tackles UK obesity with new programme
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Eli Lilly developing weight loss pill to rival injections
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Delhi fake drug racket targets J&J and GSK products
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
FDA approves groundbreaking Alzheimer's drug
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
European Pharma Stocks Hit 3-Month Low on Tariff Fears
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Novo Nordisk diabetes drug sales slow sharply
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Trump's pharma tariffs could hit UK drug prices
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Trump’s Plan to Slash Drug Prices Sparks Big Pharma Backlash
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Starmer's bold plan to cut UK drug prices
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Trump urges UK pharma to cut NHS drug costs
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
Trump tariffs may hike Aussie medicine prices
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Moderna cuts 150 jobs in cost-reduction move
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
AstraZeneca CEO warns of Trump tariffs impact
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Wegovy sales boost Novo Nordisk shares
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
AstraZeneca shares drop after US legal setback
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
Couple sentenced for illegal sex pill operation
A US couple has been sentenced after authorities discovered their home packed with illegal erectile dysfunction drugs worth thousands.
AstraZeneca invests $1.5bn in US despite Trump tariff threats
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.
UK heatwave drives retail sales surge
Soaring temperatures in June drove UK consumers to spend heavily on cooling products, lifting retail sales figures despite broader economic pressures.
Page 4 of 4